The U.S. Patent and Trademark Office continues to provide tools and resources to inventors who have developed technology relating to COVID-19.  On May 8th, the USPTO announced a prioritized examination pilot program for small and micro entities that file COVID-19 related patent applications.  The pilot program allows qualifying applications to be taken out of turn for examination, without requiring the significant Track One fees.  See my prior blog post regarding information about this program.

Today, the USPTO announced it has established a webpage with important information regarding the pilot program, including the new Certification and Request for COVID-19 Prioritized Examination form, PTO/SB/450.

The pilot program will initially run until the Office has accepted 500 requests.  After 500 requests have been accepted, the USPTO may extend the pilot program (with or without modifications) or terminate it, depending on the workload and resources needed to administer the program, feedback from the public, and the effectiveness of the program.

The USPTO webpage also includes guidance for filing the request to participate in the pilot program, as well as answers to common questions.  This pilot program offers an excellent opportunity for small and micro entities to take advantage of accelerated examination, while exempting those inventors from the prioritized exam fees.

Please feel free to contact me if you have questions or are interested in learning more about this new pilot program.

Today the USPTO announced a pilot program that will grant requests for prioritized examination to applicants that qualify for small or micro entity status without payment of the typical fees due for this accelerated examination track.

This is a great opportunity for independent inventors and small businesses to accelerate the examination process of their patent applications without the high fees typically associated with the prioritized examination (Track One) process.  Those fees can typically be in the range of $1,000 to $2,000 for small and micro entities.

The pilot program will accept a total of 500 requests under this initial phase.  After that point, the USPTO may decide to extend the pilot program, may modify the program, or may terminate it.

To qualify for the pilot program, the following conditions must be met:

1. The applicant must qualify for small or micro entity status;
2. The patent application must include at least one pending claim covers a product or process related to COVID-19 that is subject to FDA approval for use in the prevention and/or treatment of COVID-19
3. The application must be a nonprovisional utility or plant patent application;
4. The application cannot claim priority to multiple nonprovisional or international applications; and
5. The application cannot include more than 4 independent claims and 30 total claims (with no multiple dependent claims).

The objective of the pilot program is to complete, on average, the examination of an application within 12 months of special status being granted.  The press release can be found here.

The Federal Register Notice recommends practitioners use Form PTO/SB/450 to make the request for prioritized examination under the pilot program.  Once that form is available, I will update the link in this article.

Please feel free to contact me if you have questions or are interested in learning more about this new pilot program.